دورية أكاديمية

The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARalpha gene rearrangements.

التفاصيل البيبلوغرافية
العنوان: The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARalpha gene rearrangements.
المؤلفون: Orfao A; Servicio General de Citometría, Hospital Universitario Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain. orfao@gugu.usal.es, Chillón MC, Bortoluci AM, López-Berges MC, García-Sanz R, Gonzalez M, Tabernero MD, García-Marcos MA, Rasillo AI, Hernández-Rivas J, San Miguel JF
المصدر: Haematologica [Haematologica] 1999 May; Vol. 84 (5), pp. 405-12.
نوع المنشور: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print Cited Medium: Print ISSN: 0390-6078 (Print) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE
أسماء مطبوعة: Publication: 1999- : Pavia, Italy : Ferrata Storti Foundation
Original Publication: Pavia [etc.]
مواضيع طبية MeSH: Gene Rearrangement*, Antigens, CD/*blood , Leukemia, Myeloid, Acute/*physiopathology , Neoplasm Proteins/*genetics , Receptors, Retinoic Acid/*genetics, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antigens, CD34/blood ; CD13 Antigens/blood ; Child ; Female ; Flow Cytometry ; Humans ; Leukemia, Myeloid, Acute/genetics ; Leukemia, Myeloid, Acute/immunology ; Lewis X Antigen/blood ; Male ; Middle Aged
مستخلص: Background and Objective: Rapid identification of AML patients carrying the t(15;17) translocation for treatment decision-making is currently made on the basis of morphologic screening. However, the existence of both false positives and negatives highlights the need for more objective methods of screening AML cases and further molecular confirmation of the t(15;17) translocation.
Design and Methods: In the present study we analyzed a total of 111 AML cases in order to investigate whether immunophenotyping based on the assessment of multiple-stainings analyzed at flow cytometry could improve the sensitivity and specificity of morphologic identification of acute promyelocytic leukemia (APL) carrying the t(15;17) translocation. FISH analysis was used as a complementary technique for cases in which morphology and molecular biology yielded discrepant results.
Results: Concordant results between morphology and RT-PCR were found in 102/111 (91.8%) cases: 34 patients had M3/PML-RARalpha+ and 68 non-M3/PML-RARalpha- disease. Nine cases showed discrepants results. Multivariate analysis showed that the best combination of immunologic markers for discriminating between M3/PML-RARalpha+ and non-M3/PML-RARalpha- cases was that of the presence of heterogeneous expression of CD13, the existence of a single major blast cell population, and a characteristic CD34/CD15 phenotypic pattern (p<0.02). A score system based on these parameters was designed, and the 34 M3/PML-RARalpha+ cases showed a score of 3 (presence of the 3 phenotypic characteristics). In contrast, only 1 out of the 68 (1.3%) non-M3/PML-RARalpha- cases had this score, most o these latter cases (53/68, 78%) scoring either 0 or 1. Therefore, among these cases, immunophenotyping showed a sensitivity of 100% and a specificity of 99% for predicting PML/RARalpha gene rearrangements. Of the 9 cases in which morphology and molecular biology results were discrepant, four cases displayed M3 morphology without PML/RARalpha rearrangements by RT-PCR. In only one of these 4 cases did the immunophenotype score 3, this being the only FISH positive case. From the remaining five discrepant cases (non-M3 morphology while positive for PML/RARalpha) two cases had a phenotypic score of 3 and were FISH positive while the other three were negative by FISH. Upon repeating RT-PCR studies, two of these latter three cases became negative.
Interpretation and Conclusions: Our results show that immunophenotyping may be of great value for quick screening of APL with PML/RARalpha rearrangements.
المشرفين على المادة: 0 (Antigens, CD)
0 (Antigens, CD34)
0 (Lewis X Antigen)
0 (Neoplasm Proteins)
0 (Receptors, Retinoic Acid)
EC 3.4.11.2 (CD13 Antigens)
تواريخ الأحداث: Date Created: 19990518 Date Completed: 19990803 Latest Revision: 20171116
رمز التحديث: 20240627
PMID: 10329918
قاعدة البيانات: MEDLINE